UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 861177
NEW YORK, NY
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,533,248,041
+$167,998,439 QoQ
Shares Held
3,086,683
+1.0% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#15
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. VRTX ranks #1 (35.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,533,248,041 | 3,086,683 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,365,249,602 | 3,057,396 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,360,432,709 | 3,000,778 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,130,710,495 | 2,887,117 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,365,638,974 | 3,067,473 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,240,885,145 | 2,559,476 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $937,976,485 | 2,329,219 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,135,477,930 | 2,441,468 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,211,325,744 | 2,584,327 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,022,474,188 | 2,446,052 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,057,874,931 | 2,599,904 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $964,560,858 | 2,773,799 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $989,476,249 | 2,811,731 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $885,892,080 | 2,811,731 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $845,956,744 | 2,929,416 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $914,567,674 | 3,158,692 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $879,836,855 | 3,122,314 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $819,272,772 | 3,139,337 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $771,725,121 | 3,514,231 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $500,428,338 | 2,758,853 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $494,325,173 | 2,451,645 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $444,718,932 | 2,069,519 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $493,281,043 | 2,087,167 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $439,213,377 | 1,614,043 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $451,010,805 | 1,553,549 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $333,921,417 | 1,403,326 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||